INVO Fertility, Inc., a life science portfolio company, develops clinical stage assets to treat patients with fertility, oncology, and autoimmune diseases. The company operates in two divisions, NAYA Women's Health and NAYA Therapeutics. Its lead product includes NY-303, a GPC3-targeted FLEX-NK bispecific antibody that is in Phase I/II clinical trials for hepatocellular carcinoma, as well as solid and pediatric tumors; and NY-338, a CD38-targeted FLEX-NK bispecific antibody for multiple myeloma...
                
             
         
    
    
                    Industry: Medical Devices
        
                    Sector: Healthcare
        
                    Phone: 978-878-9505
        
        
                    
        
                            
                Address:
                5582 Broadcast Court, Sarasota, United States